A pharmaceutical company has recalled nearly 90,000 bottles of children’s ibuprofen for the potential presence of a foreign substance.
Strides Pharma, Inc., headquartered in India, has recalled about 89,592 bottles of its Children’s Ibuprofen Oral Suspension, according to a Food and Drug Administration (FDA) Enforcement Report. The bottles may contain a foreign substance, as the company received complaints about a gel-like mass and black particles in the product.
On March 16, the FDA recognized the recall as a Class II recall, which means “use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
USA TODAY reached out to Strides Pharma for more information about the recall, but has not received a response. Here’s what we know.
What Children’s Ibuprofen Is Affected by the Recall?
The recall is for Strides Pharma’s 100-milligram Children’s Ibuprofen Oral Suspension, sold in a 4-fluid-ounce bottle. The lot numbers for the affected bottles are 7261973A and 7261974A, and the medication expires on Jan. 31, 2027, according to the FDA report. The recall number is D-0390-2026.
What to Do if You Own Recalled Children’s Ibuprofen
Consumers who have the recalled ibuprofen should stop using it immediately.
Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at [email protected].
This article originally appeared on USA TODAY: Nearly 90,000 bottles of children’s ibuprofen recalled. See product.
Reporting by Greta Cross, USA TODAY / USA TODAY
USA TODAY Network via Reuters Connect